A simplified, sensitive immunohistochemical detection system employing signal amplification based on fluorescyl-tyramide/antifluorescein antibody reaction: its application to pathologic testing and research.
The catalyzed signal amplification (CSA) technique, based on the peroxidase-mediated deposition of haptenized tyramide and also known as tyramide signal amplification and catalyzed reportor deposition systems, is widely accepted as a signal amplification method for immunohistochemistry and in situ hybridization. In this study, we examined the applicability of a new simplified CSA system employing fluorescyl-tyramide (FT) to pathologic testing and research with formalin-fixed, paraffin-embedded tissues. By using the FT, instead of biotinyl-tyramide (BT) that is commonly employed in the CSA system with chromogen, nonspecific staining caused by endogenous biotin was completely avoided. The FT-CSA system loaded on the automated immunostaining equipment also allowed for more reproducible detection in short times. When applied to cyclin D1 immunostaining that is important in differentiation among small B-cell lymphomas, the system was useful in demonstrating its protein expression in mantle cell lymphomas considered negative or equivocally positive for cyclin D1 in a conventional immunodetection. In immunohistochemistry for phosphorylated proteins and murine hematologic markers that often require higher sensitivity than conventional methods, the FT-CSA system provided desirable staining results with intense signal amplification. Our results indicate that the simplified CSA system employing the FT can be useful in enlarging the target range for routine immunohistochemistry due to its high applicability.
Hatanaka
Yutaka
Y
Department of Medical Science, Dako Japan, Inc, Kakkyoyama 18, Shijo-Nishinotoin-higashiiru, Shimogyo, Kyoto, Japan. yutaka.hatanaka@dako.com
Imaoka
Yuki
Y
Torisu
Kae
K
Kamihara
Yuki
Y
Hashizume
Kaoru
K
Ichimura
Koichi
K
Yoshino
Tadashi
T
Tani
Yoichi
Y
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology; D001710:Biotin / Q000031:analogs & derivatives; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007150:Immunohistochemistry / Q000379:methods*; D051379:Mice; D016513:Mice, SCID; D008856:Microscopy, Fluorescence / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000378:metabolism; D016612:Paraffin Embedding; D012680:Sensitivity and Specificity; D014439:Tyramine / Q000031:analogs & derivatives
D000906:Antibodies; D000951:Antigens, Neoplasm; C111551:biotinyltyramide; D001710:Biotin; D014439:Tyramine